Homogeneous enzyme-linked assays mediated by enzyme antibodies; a new approach to electrode-based immunoassays by Brontman, Susan B. & Meyerhoff, Mark E.
Analytica Chimica Acta, 162 (1984) 363-367 
Elsevier Science Publishers B.V., Amsterdam - Printed in The Netherlands 
Short Communication 
HOMOGENEOUS ENZYME-LINKED ASSAYS MEDIATED BY 
ENZYME ANTIBODIES; A NEW APPROACH TO ELECTRODE-BASED 
IMMUNOASSAYS 
SUSAN B. BRONTMAN and M. E. MEYERHOFF* 
Department of Chemistry, The University of Michigan, Ann Arbor, MI 48109 (U.S.A.) 
(Received 30th March 1984) 
Summary. A new homogeneous enzyme-immunoassay system is described. The assay 
employs an ammonia-liberating enzyme covalently coupled to protein antigens along with 
two antibodies. An anti-enzyme antibody inhibits the enzyme. However, an antibody 
selective for the antigen reverses the inhibition process. When samples containing free 
antigen are present in the assay mixture, there is competition for anti-antigen antibody 
sites and protection against the anti-enzyme antibodies is diminished. The extent of the 
enzymatic reaction is monitored with an ammonium ion-selective electrode. Preliminary 
data demonstrating the feasibility of this approach for human serum albumin are presented. 
The development of novel non-isotopic competitive binding immunoassays 
for the detection of antigens in physiological fluids has become an important 
area of bioanalytical research. Such assays offer attractive alternatives to the 
more traditional radioimmunoassay methods. Enzymes have emerged recently 
as effective labels for immunoassay methods [l-3] . This communication 
describes a new homogeneous enzyme immunoassay arrangement. 
The proposed assay (see Fig. 1) utilizes the enzyme, adenosine deaminase 
(ADA), which catalyzes the hydrolysis of adenosme to inosine and ammonia 
[4]. The enzyme is covalently coupled to an analyte protein. Also, two anti- 
body reagents are required, one selective for the protein to be measured and 
a second one directed toward the active site of the enzyme. When antibodies 
selective for the antigen are first added to the enzyme conjugate, these anti- 
bodies partially protect the enzyme from inhibition when the enzyme anti- 
bodies are added, thereby increasing the catalytic activity observed. When 
samples containing free antigen are present in the assay mixture, a competi- 
tion for the anti-antigen antibody sites occurs and protection against the 
anti-enzyme antibodies is diminished. The extent of the enzymatic reaction 
can be monitored with an ammonium ion-selective electrode. 
The feasibility of this new assay approach is demonstrated by developing 
an assay for the model protein, human serum albumin (HSA). The factors 
which limit sensitivity and speed of the assay are discussed as are prospects 
for improving the overall quantitative characteristics of the technique. 
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Fig. 1. Representation of reagents used and processes that take place in the proposed assay. 
Experimental 
Apparatus. Potentiometric measurements were made with a tubular flow- 
through ammonium ion-selective electrode based on nonactin [ 51 in an auto- 
atic continuous flow arrangement. Fractions obtained from size-exclusion 
chromatography of ADA-HSA conjugates were collected with an ISCO 
model 1850 fraction collector with continuous photometric monitoring of 
the effluent. All incubations for the enzyme immunoassays were performed 
in 3-ml borosilicate glass tubes. 
Reagents. Reagents obtained from Sigma Chemical Company were adeno- 
sine deaminase (ADA) type III from calf intestinal mucosa, human serum 
albumin (HSA) fraction V, adenosine, tris(hydroxymethyl)aminomethane 
(Tris), Sephadex G-100, and glutaraldehyde (grade I, aqueous 25% solution). 
All other chemicals were reagent grade. Standards and working buffer solu- 
tions were prepared with distilled-deionized water. 
A 0.01 M Tris/sulfuric acid buffer, pH 7.5, containing 0.5 mM ethylene- 
diaminetetraacetic acid [4] was used as the working buffer. A 0.1 M phos- 
phate buffer, pH 7.0, was used when preparing ADA-HSA conjugates via 
the glutaraldehyde cross-linking reaction. 
Antisera were prepared and provided by the Unit for Laboratory Animal 
Medicine at the University of Michigan. For working antibody reagents, each 
antiserum lot was subjected to an ammonium sulfate fractionation to isolate 
the y-globulin components of the serum [6] . 
Preparation and purification of ADA-HSA conjugates. The ADA was 
cross-linked to HSA by a glutaraldehyde reaction [7]. The conjugate was 
prepared by mixing 2 mg of HSA and 0.20 mg of ADA in 2 ml of phosphate 
buffer. The protein solution was dialyzed extensively against three l-l 
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volumes of the phosphate buffer. The solutions were then placed in a glass 
test tube and gently stirred as 150 ~1 of 1% glutaraldehyde was added in 
50-~1 increments over the first 2 h of the reaction. After 4 h, the reaction 
mixture was centrifuged at 2200 g for 15 min at 4°C. The supernatant solu- 
tions were then dialyzed against the Tris working buffer. These conjugates 
were then partly purified as follows: a fraction of the conjugate was passed 
through a Sephadex G-100 size-exclusion column and the effluent was con- 
tinuously monitored at 280 nm. As protein began to elute, 0.5-ml fractions 
were collected. 
Determination of relative ADA activity. Aliquots (10 ~1) of ADA or 
ADA-HSA conjugates (from the fractions) were added to 1.49 ml of working 
buffer in test tubes and 50 ~1 of 5 mM adenosine solution was added to 
initiate the reaction. After 15 or 60 min (depending on the absolute activity 
of the ADA in the sample), 50 ~1 of 0.02 M silver nitrate was added to the 
tube to stop the enzymatic reaction. Ammonium ions produced were quan- 
tified and corrected for amounts produced in a similar blank reaction. 
Only fractions from the size-exclusion column with highest protection 
characteristics were used in subsequent assays by the proposed method. 
Procedure for calibration curves for HSA. Assays were run in triplicate. 
First, 1.10 ml of working buffer was added to each tube followed by 100 ~1 
of an HSA standard solution and 100 ~1 of diluted HSA antibody. After 
20 min, 100 ~1 of diluted HSA-ADA conjugate was added and the mixture 
was incubated at room temperature for another 20 min. Subsequently, 100 ~1 
of the diluted ADA antibody reagent was added and after another 20 min of 
incubation, 50 ~1 of adenosine solution was added and silver nitrate was 
added after 1 h. The ammonium content was determined as described above. 
Calibration curves were constructed by arbitrarily assigning the amount 
of ammonium ions produced from the “protected” enzyme conjugate as 
100% activity and that level produced from the inhibited conjugate as 0%. 
Results and discussion 
The pure ADA used here was inhibited up to a maximum of 72% even in 
the presence of excess of the anti-ADA antibody preparation. Nearly maxi- 
mum inhibition (70%) could be achieved using a 1:lOO dilution of this anti- 
body. Fractions of the ADA-HSA conjugate most effective for the proposed 
type of assay were also generally inhibited up to 70% with the same 1:lOO 
dilution of the antibody preparation. Thus, the covalent attachment of HSA 
to the enzyme apparently does not preclude inhibition of the enzyme by 
anti-ADA antibodies. None of the ADA-HSA fractions obtained from the 
size-exclusion procedure exhibited full activity in the presence of anti-HSA 
antibodies. The ADA-HSA conjugates prepared to date are activated (pro- 
tected) up to 32% (e.g., from 70% to 38% inhibition) in the presence of 
anti-HSA antibodies. Despite this rather narrow range of enzyme modulation, 
the conjugates prepared were useful to demonstrate the principle of the new 
method. 
MOLES 01 PROTBIN PER TUBE 
1.0 
MICROQRAYS of PROTEIN PER TUBE 
Fig. 2. Calibration curve obtained for detection of free HSA (0); data points shown are 
average of triplicate measurements with standard deviation. Also shown is the response of 
the system to varying free myoglobin levels (A). 
Figure 2 shows a typical calibration curve obtained when free HSA con- 
centrations were varied with an ADA-HSA conjugate fraction that can be 
protected up to 32%. It can be seen that the reproducibility is quite good for 
triplicate samples; slightly less than 1 c(g of HSA protein could be detected, 
which is similar to the detection limit of another homogeneous enzyme 
immunoassay [8]. Figure 2 also shows that increasing concentrations of 
myoglobin did not significantly affect the ability of anti-HSA antibodies to 
protect the ADA-HSA conjugate. 
The use of a new, more controllable cross-linking reagent, N-succinimidyl 
3-(2-pyridyldithio)propionate [ 91, may permit detection limits and assay 
times to be reduced by producing an ADA-HSA conjugate that is more fully 
protected; work in this direction is currently under way. In addition, size- 
exclusion chromatography with gels possessing larger fractionation ranges 
should also aid in obtaining a more suitable conjugate. 
Data presented here demonstrate the feasibility of the proposed approach. 
It is expected to be applicable with other enzymes, other antigens, and other 
types of detectors. Modifications of the experimental system would be 
required for clinical samples. 
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